These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 1834933)
1. Growth stimulation and differential regulation of transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, and TGF beta 3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cells. Jeng MH; Jordan VC Mol Endocrinol; 1991 Aug; 5(8):1120-8. PubMed ID: 1834933 [TBL] [Abstract][Full Text] [Related]
2. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation. Jeng MH; Parker CJ; Jordan VC Cancer Res; 1992 Dec; 52(23):6539-46. PubMed ID: 1423300 [TBL] [Abstract][Full Text] [Related]
3. Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells. Jeng MH; Langan-Fahey SM; Jordan VC Endocrinology; 1993 Jun; 132(6):2622-30. PubMed ID: 8504763 [TBL] [Abstract][Full Text] [Related]
4. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions. Murphy CS; Pink JJ; Jordan VC Cancer Res; 1990 Nov; 50(22):7285-92. PubMed ID: 2224859 [TBL] [Abstract][Full Text] [Related]
5. [Effects of estrogen and endocrine therapeutic agents on the estrogen receptor, progesterone receptor and DNA synthesis in MCF-7 human breast cancer cells using the whole cell uptake method]. Kurebayashi J; Horiuchi R; Nakamura T; Iino Y; Ishida T; Takigawa H; Izuo M Nihon Naibunpi Gakkai Zasshi; 1987 Nov; 63(11):1351-63. PubMed ID: 2965035 [TBL] [Abstract][Full Text] [Related]
6. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth. Herman ME; Katzenellenbogen BS Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416 [TBL] [Abstract][Full Text] [Related]
7. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Read LD; Greene GL; Katzenellenbogen BS Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242 [TBL] [Abstract][Full Text] [Related]
8. Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines. Schoonen WG; Joosten JW; Kloosterboer HJ J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):423-37. PubMed ID: 8541240 [TBL] [Abstract][Full Text] [Related]
9. Regulation of the levels of three transforming growth factor beta mRNAs by estrogen and their effects on the proliferation of human breast cancer cells. Jeng MH; ten Dijke P; Iwata KK; Jordan VC Mol Cell Endocrinol; 1993 Nov; 97(1-2):115-23. PubMed ID: 8143893 [TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins. Gong Y; Anzai Y; Murphy LC; Ballejo G; Holinka CF; Gurpide E; Murphy LJ Cancer Res; 1991 Oct; 51(20):5476-81. PubMed ID: 1833051 [TBL] [Abstract][Full Text] [Related]
11. Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol. Arrick BA; Korc M; Derynck R Cancer Res; 1990 Jan; 50(2):299-303. PubMed ID: 2295070 [TBL] [Abstract][Full Text] [Related]
12. Regulation of transforming growth factor alpha and transforming growth factor beta messenger ribonucleic acid abundance in T-47D, human breast cancer cells. Murphy LC; Dotzlaw H Mol Endocrinol; 1989 Apr; 3(4):611-7. PubMed ID: 2524651 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells. Murphy LC; Dotzlaw H; Wong MS; Miller T; Murphy LJ Cancer Res; 1991 Apr; 51(8):2051-7. PubMed ID: 1849041 [TBL] [Abstract][Full Text] [Related]
14. Hormonal regulation of estrogen receptor messenger ribonucleic acid in T47Dco and MCF-7 breast cancer cells. Berkenstam A; Glaumann H; Martin M; Gustafsson JA; Norstedt G Mol Endocrinol; 1989 Jan; 3(1):22-8. PubMed ID: 2915647 [TBL] [Abstract][Full Text] [Related]
15. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival. Menendez JA; Oza BP; Colomer R; Lupu R Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863 [TBL] [Abstract][Full Text] [Related]
16. The effects of a constitutive expression of transforming growth factor-alpha on the growth of MCF-7 human breast cancer cells in vitro and in vivo. Clarke R; BrĂ¼nner N; Katz D; Glanz P; Dickson RB; Lippman ME; Kern FG Mol Endocrinol; 1989 Feb; 3(2):372-80. PubMed ID: 2710138 [TBL] [Abstract][Full Text] [Related]
17. Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Bates SE; Davidson NE; Valverius EM; Freter CE; Dickson RB; Tam JP; Kudlow JE; Lippman ME; Salomon DS Mol Endocrinol; 1988 Jun; 2(6):543-55. PubMed ID: 3047554 [TBL] [Abstract][Full Text] [Related]
18. Retinoid antagonism of estrogen-responsive transforming growth factor alpha and pS2 gene expression in breast carcinoma cells. Fontana JA; Nervi C; Shao ZM; Jetten AM Cancer Res; 1992 Jul; 52(14):3938-45. PubMed ID: 1319834 [TBL] [Abstract][Full Text] [Related]
19. Interleukin 1 alpha blocks estradiol-stimulated growth and down-regulates the estrogen receptor in MCF-7 breast cancer cells in vitro. Danforth DN; Sgagias MK Cancer Res; 1991 Mar; 51(5):1488-93. PubMed ID: 1997187 [TBL] [Abstract][Full Text] [Related]
20. Dose-dependent changes of the ratio of apoptosis to proliferation by norethisterone and medroxyprogesterone acetate in human breast epithelial cells. Seeger H; Rakov V; Mueck AO Horm Metab Res; 2005 Aug; 37(8):468-73. PubMed ID: 16138258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]